Cosmic Stocks

[ProfitScout]

$SGBX: Safe & Green Holdings Announces LOI for Transformative Acquisition of Olenox and Machfu.com

Strategic Transaction Introduces Game-Changing Energy and IoT Innovations, Setting the Stage for Long-Term Shareholder Value

Michael McLaren appointed Chairman of Safe & Green

MIAMI, FL, Jan. 14, 2025 (GLOBE NEWSWIRE) -- Safe & Green Holdings Corp. (NASDAQ: SGBX) (“Safe & Green Holdings” or the “Company”), a leading developer, designer, and fabricator of modular structures, today announced the execution of a binding Letter of Intent (“LOI”) to acquire 100% of the outstanding securities of New Asia Holdings Inc. (OTCQB: NAHD) (“NAHD”). The acquisition includes a diversified energy company Olenox Corp. (“Olenox”), a wholly owned subsidiary of NAHD. The acquisition also includes Machfu.com (“Machfu”), a wholly owned subsidiary of Olenox, specializing in secure connectivity and automation solutions for industries such as oil & gas, utilities, and manufacturing.

Olenox’s operations include three vertically integrated business units: Oil & Gas Production, Energy Services, and Energy Technologies. Olenox specializes in acquiring and revitalizing underdeveloped energy assets, leveraging proprietary technologies and operational expertise to enhance production efficiency, lower costs, and minimize environmental impact.

Key achievements of Olenox include expanding production from 113 barrels of oil equivalent per day (BOE/day) to a projected 700 BOE/day through increased operational capacity and innovative technologies. By focusing on distressed and neglected oil and gas fields in Texas, Oklahoma, and Kansas, Olenox has created a scalable model that addresses industry inefficiencies while maintaining a strong commitment to sustainability. Following the acquisition of NAHD, Safe & Green will continue to maintain its current operations and fabrication of modular structures. In addition, the Company plans to leverage its existing facilities, including its Waldron facility in Durant, Oklahoma, to support its new operations in the oil and gas industry. Company management expects that this dual focus will enable the combined entity to achieve greater efficiencies and benefit from economies of scale across its business segments. This approach aligns with the Company’s overarching vision to lead advancements in sustainable energy, food, water, and shelter as essential pillars for fostering global resilience.

Olenox’s proprietary plasma pulse and ultrasonic cleaning tools set it apart from traditional energy players. These advanced technologies allow for cost-effective recovery of oil and gas while reducing the environmental footprint, ensuring alignment with global sustainability trends. Olenox’s Energy Services division, with its customized service rigs and reclamation capabilities, enhances the value of its production assets while generating additional revenue streams through third-party contracts.

Machfu.com is a trailblazer in the Industrial IoT sector. Its flagship product, the MachGateway®, and Edge-to-Enterprise™ software enable seamless integration of legacy systems with modern IoT platforms. With over 20,000 gateways deployed globally, Machfu has proven its ability to deliver real-time data analytics, predictive maintenance, and operational efficiency to industrial clients.

Machfu’s technology supports cost reduction and productivity gains by minimizing downtime and optimizing equipment performance. For example, its Bluetooth IoT gateways connect over 125 sensors per device, enabling scalable, low-cost solutions for monitoring and control in industrial environments. These capabilities directly address the growing demand for automation and digital transformation in energy and other key industries, creating high-margin recurring revenue opportunities for the combined entity.

In connection with the transaction, Michael McLaren, recently appointed CEO of Safe & Green, as well as founder and CEO of Olenox, will assume the additional role of Chairman of Safe & Green, succeeding Paul Galvin, who will remain on Safe & Green’s board of directors. McLaren brings decades of experience in energy production, sustainability, and innovation, making him uniquely positioned to lead the company’s expanded vision.

https://ml.globenewswire.com/Resource/Download/54e2a9ad-a000-460c-9a79-5c205c295822/newly-appointed-chairman-and-ceo-michael-mclaren.png

Newly appointed Chairman and CEO Michael McLaren

Michael McLaren stated, “We believe that the combination of Olenox and Machfu with Safe & Green will create a powerful, diversified entity with robust growth potential in both the energy and technology sectors. Olenox provides stable and growing revenues from its oil and gas assets, complemented by the scalability of Machfu’s recurring IoT revenue streams. We believe that this synergy will position the combined company to capture significant market opportunities in renewable energy, digital transformation, and industrial automation. By maintaining Safe & Green’s current modular operations, while leveraging facilities such as our Waldron facility to support oil and gas activities, we expect to achieve greater operational efficiencies and economies of scale. For Safe & Green shareholders, this transaction represents a strategic pivot toward high-growth markets. Olenox’s proven financial performance, including strong asset utilization and innovative technologies, enhances the Company’s equity position and profitability potential. Machfu’s advanced IoT capabilities further diversify the revenue base, providing exposure to a rapidly growing global market. I am honored to lead this next chapter and deeply appreciate Paul Galvin’s exceptional leadership and dedication. I look forward to working closely with Paul and the board to realize our shared vision.”

Paul Galvin added, “This transaction marks an exciting milestone for Safe & Green and its shareholders. The combination of Olenox and Machfu with Safe & Green creates a powerful, diversified entity with robust growth potential in both the energy and technology sectors. We expect that this transaction will expand the Company’s addressable markets, increase operational efficiencies, and position the combined entity as a leader in innovative, sustainable solutions. Importantly, we believe leveraging existing facilities to support both modular and oil and gas operations will maximize efficiency and drive economies of scale. Moreover, Olenox is already profitable and on a strong growth trajectory. By combining their operations with our own, I am confident this transaction will drive significant value for shareholders. Furthermore, we believe this transaction will help address the Company's Nasdaq listing deficiency by strengthening our financial position. I am also thrilled to welcome Mike McLaren as Chairman as we enter this new phase of growth and innovation.”

About Safe & Green Holdings Corp.

Safe & Green Holdings Corp., a leading modular solutions company, operates under core capabilities which include the development, design, and fabrication of modular structures, meeting the demand for safe and green solutions across various industries. The firm supports third-party and in-house developers, architects, builders, and owners in achieving faster execution, greener construction, and buildings of higher value. For more information, visit https://www.safeandgreenholdings.com/ and follow us at @SGHcorp on Twitter.

No Offer or Solicitation

This communication is for informational purposes only and is not intended to and shall not constitute an offer to buy or sell or the solicitation of an offer to buy or sell any securities, or a solicitation of any vote or approval, nor shall there be any sale of securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction.

Safe Harbor Statement

Certain statements in this press release constitute "forward-looking statements" within the meaning of the federal securities laws. Words such as "may," "might," "will," "should," "believe," "expect," "anticipate," "estimate," "continue," "predict," "forecast," "project," "plan," "intend" or similar expressions, or statements regarding intent, belief, or current expectations, are forward-looking statements. These forward-looking statements are based upon current estimates and assumptions and include statements regarding the Company’s letter of intent to acquire NAHD, including its subsidiary Olenox and Olenox’s subsidiary Machfu.com, closing of such acquisition, the Company’s plans to leverage its existing facilities to support the combined company’s operations in the oil and gas industries, Olenox’s proprietary plasma pulse and ultrasonic cleaning tools that allow for cost-effective recovery of oil and gas while reducing the environmental footprint, and Machfu’s MachGateway® and Edge-to-Enterprise™ software which enable seamless integration of legacy systems with modern IoT platforms, and the Company’s ability to maintain its Nasdaq listing. These forward-looking statements are subject to various risks and uncertainties, many of which are difficult to predict that could cause actual results to differ materially from current expectations and assumptions from those set forth or implied by any forward-looking statements. Important factors that could cause actual results to differ materially from current expectations include, among others, the Company’s ability to successfully complete the transaction with NAHD, the timing to consummate the proposed acquisition, the diversion of management time on transaction-related issues, unexpected costs, charges or expenses resulting from the acquisition, potential litigation relating to the acquisition that could be instituted against the parties to the letter of intent or their respective directors, managers or officers, including the effects of any outcomes related thereto, the Company’s ability to successfully leverage its existing facilities to support its planned new operations for the combined entity in the oil and gas industries, Olenox’s ability to successfully leverage its proprietary plasma pulse and ultrasonic cleaning tools, Olenox’s ability to successfully generate additional revenue streams through third-party contracts, Machfu.com’s ability to successfully leverage its advanced IoT capabilities to diversify and increase its revenue base, the effect of government regulation, the Company’s ability to maintain compliance with the NASDAQ listing requirements, and the other factors discussed in the Company’s Annual Report on Form 10-K for the year ended December 31, 2023 and its subsequent filings with the SEC, including subsequent periodic reports on Forms 10-Q and 8-K. The information in this release is provided only as of the date of this release, and we undertake no obligation to update any forward-looking statements contained in this release on account of new information, future events, or otherwise, except as required by law.

Investor Relations:

Crescendo Communications, LLC
[phone]
[e-mail]

[ProfitScout]

$IVDN: Innovative Designs Inc. Reports Record Sales Results to Shareholders

PITTSBURGH, Pa - (NewMediaWire) - December 30, 2024 - Innovative Designs, Inc. (OTC Pink: IVDN) today issues the following letter to shareholders from new CEO Joseph A. Riccelli. This letter covers the Company's fiscal third quarter financial results and forward-looking projections, as well as a discussion of significant events in 2024 and plans for the future.

Key points in this letter include:

2024 Fiscal Third Quarter Revenues More Than Doubled Same Period in 2023.
First Nine Months of Fiscal 2024 Delivered Over a 285% Increase Over 2023.
Accelerating Order Flow and Record Backlog in 2024 vs. No Backlog in 2023.
Increasing Production Capabilities to Meet Rising Demand.
Plans for Investor Conference Call / Shareholders Meeting in the company's 2nd Quarter.

Dear IVDN Shareholders:

As the 2024 calendar year comes to a close, I would like to thank all those who have maintained an investment position and followed the developing Innovative Designs story for the marketing of our unmatched Evacuated (Vacuum) Cell R-6 Insultex House Wrap®. As reported in our latest financial filing, the Company's sales revenues for the fiscal third quarter ending July 31, 2024, reached over $250K, surpassing double the $124K total from the same period in 2023. For the trailing nine months from fiscal Q3 in 2024, revenues reached more than $640K, over a 280% increase over the $223K revenue results in 2023.

The Company's full fiscal year ended on October 31, 2024 and we are currently working to complete this financial report which will present even more rapid sales growth. We can now project a 2024 fiscal year-end total of over $1.2M. After this year-end report is filed, we will hold an investor conference call and shareholder's meeting in the second quarter. Sales growth is also continuing in our fiscal first quarter with the largest backorder for Insultex House Wrap® that the company has ever seen, by far vs. no backlog last year.

A significant catalyst to the surging sales of Insultex House Wrap® has been new government building codes calling for continuous insulation and exterior R-Value requirements which are going into effect across the USA. Insultex House Wrap® has proven to be the best overall solution to these new requirements in terms of performance, cost effectiveness and ease of installation. Insultex House Wrap® delivers all this thanks to its unique and patented vacuum cell structure design. No other product on the market today offers a vacuum cell structure. A vacuum is the best thermal insulation possible and only Insultex® incorporates countless evacuated cells. Insultex® also provides a moisture barrier and other key benefits that make it the best choice for home builders and home remodelers for jobs of any size.

Once a new customer buys Insultex House Wrap®, which is a disruptive technology in the building industry, we are finding that they continue to reorder. Insultex House Wrap® provides a substantial savings for new construction, adding an R-6 moisture barrier membrane that does not need additional insulation boards or other support as competitive products.

With the increasing demand for Insultex House Wrap®, one of our top priorities has become increasing new production to maintain a timely order flow. To this end, we have developed new production resources in the last few months which are now able to deliver higher levels of inventory for customers placing rising orders. As demand grows, we have plans for further manufacturing and production. New marketing programs and additional product certifications are also planned.

Lastly, I would like to address the corporate changes that have taken place at Innovative Designs in the last few months including the installation of myself as the new CEO, a position which I am committed to fully with high expectations. The Board of Directors has asked me to convey their sincere appreciation of my father, former CEO Joesph Riccelli, Sr. He has given the Company over 20 years of dedicated service and strong support, all while overseeing important accomplishments. Prior to stepping down as CEO earlier this year for health and family reasons, Joseph Riccelli, Sr. kept Innovative Designs functioning and developing despite many hardships. He also worked to preserve shareholder value by maintaining a small and manageable share structure which today still totals less than 40 million shares outstanding.

Going forward, we intend to keep our customers and shareholders regularly informed of our progress as we address the vital energy saving needs of the multi-billion dollar homebuilding industry. One of our top priorities will be timely filing on all of our future financial reports. We will also be exploring other marketing opportunities for our unique Insultex® material beyond the building industry. For any shareholders or home building/remodeling professionals who wish to speak to me directly I will be available by phone and email at the contact information below. My family and I, as well as everyone on the Innovative Designs team, wish you all a prosperous 2025 ahead.

Sincerely,

Joseph A. Riccelli, CEO

About Innovative Designs, Inc.

Innovative Designs, Inc. manufactures the Insultex® House Wrap and Arctic Armor® Line, under the "i.d.i.gear" label featuring INSULTEX®. Patented INSULTEX® is the thinnest, lightest and warmest insulator in the market today. For more information, please visit: http://www.insultexhousewrap.com and http://www.idigear.com

Disclaimer

Certain statements in this press release constitute "forward-looking" statements as defined by federal law. Such statements are based on assumptions, but there is no assurance that actual outcomes will not be materially different as those implied. Any such statements are made in reliance on the "Safe Harbor" protections provided under the Private Securities Reform Act of 1995 and are subject to various factors, including the risks and matters discussed in the Company's SEC filings available at http://www.sec.gov.

CONTACT:
Innovative Designs, Inc.
Joseph A. Riccelli, CEO
412-799-0350

[e-mail]
http://www.insultexhousewrap.com

[ProfitScout]

$AMOD News: Alpha Modus Appoints Accomplished Executive Thomas Gallagher as Chief Revenue Officer to Drive Growth and Maximize Shareholder Value

CORNELIUS, N.C., Jan. 10, 2025 (GLOBE NEWSWIRE) -- Alpha Modus Holdings, Inc. (Nasdaq: AMOD) (“Alpha Modus” or the “Company”), is pleased to announce the appointment of Thomas Gallagher as Chief Revenue Officer (CRO) of the Company. In this role, Mr. Gallagher will oversee global revenue generation strategies, scaling operations, and aligning the Company’s sales, marketing, and business development efforts to accelerate growth and deliver robust shareholder returns.

Mr. Gallagher brings over two decades of proven leadership in driving revenue growth, strategic expansion, and operational excellence in competitive markets. Most recently, Mr. Gallagher served as Senior Vice President of Services and Solutions at Zones, where he spearheaded transformative strategies that significantly enhanced sales and operational efficiency. Prior to that, he held pivotal roles including Chief Sales Officer of Cloud Infrastructure Services at Capgemini North America and Vice President of Sales for North and South American Industries at DXC. His extensive experience also includes senior sales positions at IBM, HP/EDS, and AT&T.

"Thomas Gallagher is an outstanding addition to the Alpha Modus leadership team," said William Alessi, CEO. "His exceptional track record of delivering measurable results and building high-performing teams, coupled with his cross-industry expertise, will be instrumental as we target scaling our business and capitalizing on growth opportunities."

Throughout his career, Mr. Gallagher has demonstrated a deep understanding of market dynamics and a commitment to fostering strong relationships with customers, partners, and stakeholders. At Alpha Modus, he will lead initiatives in sales, operations, marketing, pricing strategies, partnerships, and revenue management, positioning the company for sustainable growth and enhanced profitability.

"I am thrilled to join Alpha Modus at such a pivotal moment in its journey," said Mr. Gallagher. "The Company has built a strong foundation as an AI innovator and IP owner and is well-positioned for continued success. I look forward to working with the talented team to drive innovation, unlock new revenue opportunities, and create lasting value for our shareholders."

This strategic appointment underscores Alpha Modus’ commitment to advancing its growth strategy and delivering long-term value to its stakeholders. As Mr. Gallagher steps into this critical leadership role, Alpha Modus is squarely focused on achieving ambitious revenue targets and establishing its position as an industry leader.

About Thomas Gallagher

Mr. Gallagher is a seasoned technology executive with a robust background in sales and go-to-market leadership. A graduate of the United States Naval Academy with a degree in Systems Engineering, he served as a Captain in the United States Marine Corps for five years. He currently resides in New Jersey.

About Alpha Modus

Alpha Modus engages in creating, developing and licensing data-driven technologies to enhance consumers’ in-store experience at the point of decision. Alpha Modus’s patent portfolio positions the Company as a leader in the evolving landscape of AI retail technology. With the ability to transform how consumers interact with brands at the point of sale, Alpha Modus is strategically positioned to capitalize on the increasing demand for AI-driven solutions that deliver measurable ROI for retailers and brands.

For additional information, please visit alphamodus.com.

Forward-Looking Statements

This press release includes “forward-looking statements” within the meaning of the “safe harbor” provisions of the United States Private Securities Litigation Reform Act of 1995. Alpha Modus’ actual results may differ from their expectations, estimates, and projections and, consequently, you should not rely on these forward-looking statements as predictions of future events. Words such as “expect,” “estimate,” “project,” “budget,” “forecast,” “anticipate,” “intend,” “plan,” “may,” “will,” “could,” “should,” “believes,” “predicts,” “potential,” “continue,” and similar expressions (or the negative versions of such words or expressions) are intended to identify such forward-looking statements, but are not the exclusive means of identifying these statements. These forward-looking statements include, without limitation, Alpha Modus’ expectations with respect to future performance.

Alpha Modus cautions readers not to place undue reliance upon any forward-looking statements, which speak only as of the date made. Alpha Modus does not undertake or accept any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements to reflect any change in its expectations or any change in events, conditions, or circumstances on which any such statement is based.

Contacts:

Alpha Modus Holdings, Inc.

Investor Relations

[e-mail]

[phone]

https://www.globenewswire.com/newsroom/ti?nf=OTMyOTMwOSM2Njc5MjYwIzIyNjM1NDM=
https://ml.globenewswire.com/media/ODM5YWI1M2QtYTQ3OC00ZDZlLTg5YWItYWRjNTU3ZjE0NTcyLTEyNzUwOTM=/tiny/Alpha-Modus-Corp-.png

Source: Alpha Modus Corp.

[ProfitScout]

$RENB News: RenovaroCube Receives Approval of Lumina Project by the Eurostars Funding Program

LUMINA is an Advanced Minimal Residual Disease Detection Platform for Lung Cancer Harnessing the Power of Multi-omics Biomarkers and AI

LOS ANGELES and AMSTERDAM, Dec. 23, 2024 (GLOBE NEWSWIRE) -- Renovaro Inc. (NASDAQ: RENB), a pioneer in cancer diagnostics and therapeutics powered by artificial intelligence, today announced its subsidiary RenovaroCube (the ‘Cube’), a leader in AI-driven cancer diagnostics by integrating multi-omics with liquid biopsies, together with its consortium partners Flomics Biotech, Uppsala Universitet and Oncodia, received grant funding approval for the Lumina project from the Eurostars funding program after review by an independent expert panel.

Eurostars is part of the European Partnership on Innovative SMEs (Small and Medium-sized Enterprises). The partnership is co-funded by the European Union through Horizon Europe. Eurostars is the largest international funding program for SMEs wishing to collaborate on R&D projects that create innovative products, processes or services for commercialization, with over €250M in expected public-private investment each year.

The Lumina project aims to deliver an advanced Minimal Residual Disease (MRD) detection platform for lung cancer. Harnessing the power of multi-omics biomarkers and AI-driven technology, this platform aims to transform recurrence risk prediction and treatment strategies for millions of patients worldwide.

“This award further validates our purpose-built AI platform in facilitating the discovery of biomarkers critical for early cancer detection, monitoring, and treatment personalization,” said David Weinstein, Chief Executive Officer of Renovaro. “In partnership with leading institutions and companies, including Uppsala University, Oncodia AB, and Flomics Biotech, the Lumina project is focused on improving lung cancer patient survival. Over 5.7 million lung cancer cases are treated or monitored globally each year, and of all curatively treated lung cancer patients, 60% will relapse. Lumina represents a significant opportunity to address this critical issue, and we look forward to continuing work with our partners to bring this product to market.”

A High-Performance Platform for Better Outcomes

The objective of the LUMINA project is to develop a cutting-edge platform designed to provide unparalleled accuracy in detecting minimal residual disease. To achieve this, liquid biopsies combined with multi-omics biomarker technology, represent a revolutionary approach. The LUMINA project’s AI-powered platform capitalizes on this potential, aiming to provide a highly accurate, non-invasive solution that addresses a critical unmet need in lung cancer care.

Collaborative Expertise

The LUMINA project is built on a strong foundation of collaboration with leading institutions and companies, including Uppsala University, Oncodia AB, and Flomics Biotech. These partnerships bring together world-class clinical expertise and a multi-omic approach, leveraging the analysis of cell-free DNA and RNA to ensure the platform’s success.

About Renovaro

Renovaro https://renovarogroup.com/ aims to accelerate precision and personalized medicine for longevity powered by mutually reinforcing AI and biotechnology platforms for early diagnosis, better-targeted treatments, and drug discovery. Renovaro Inc. includes RenovaroBio with its advanced cell-gene immunotherapy company and RenovaroCube.

About RenovaroCube

RenovaroCube is a pioneer in AI-based molecular diagnostics, committed to revolutionizing healthcare through advanced data analysis. Its platform integrates cutting-edge AI capabilities with state-of-the-art HPC infrastructure to provide unparalleled insights into multi-omic data for early detection of diseases based on non-invasive testing using liquid biopsy (blood).

RenovaroCube’s AI platform is purpose-built to process and analyze multi-omic molecular data, facilitating the discovery of biomarkers critical for early cancer detection, monitoring, and treatment personalization. Originally developed for the fintech sector, this platform is being reengineered for healthcare, offering:

Sequence Processing: Transform raw molecular data from patient samples into clean, analyzable formats using advanced sequencing and alignment technologies, ensuring the highest quality for downstream analysis.
Biomarker Discovery: Harness unique algorithms and multi-omic pipelines to identify biologically relevant cancer biomarkers, providing critical insights into disease mechanisms and potential therapeutic targets.
AI Factory: Employ sophisticated machine learning models to predict cancer presence, origin, and stage based on extracted biomarker features. These models are trained on vast datasets to enhance accuracy and reliability, supporting early detection and personalized treatment strategies.
Precision Diagnostics: Offer an interactive interface for visualizing data, generating comprehensive clinical reports, and delivering actionable insights across various omic layers and biomarkers. This interface empowers healthcare professionals to make informed decisions with confidence.
About Flomics Biotech, S.L.

Flomics https://www.flomics.com/ is a fast-growing biotech company based in Barcelona, operating in the genomics and liquid biopsy space. Flomics’ objective is to develop a revolutionary diagnostic blood test based on Next-Generation Sequencing (NGS) of cell-free RNA, suitable for the early detection of different complex diseases, in particular cancer. Additionally, as CRO, Flomics also offers the following services: biomarker discovery (on tissue and biofluids), support on bioinformatic analysis and an intuitive web-based platform suitable for the analysis of NGS data (Stratus). The team at Flomics has a strong background in RNA and liquid biopsy, as well as advanced bioinformatics analysis methods.

About Uppsala Universitet

Uppsala University is the first university in the Nordic countries and a world-class research institution. The Department of Immunology, Genetics and Pathology is dedicated to advancing cancer diagnostics and treatment through the study of molecular changes associated with cancer. The research aims to harness measurable molecular information to improve diagnosis and therapy, with a strong focus on developing liquid biopsy-based diagnostic tests. A key initiative is the U-CAN project, which provides a unique biobank of high-quality clinical samples and data from cancer patients to support translational research. This effort, combined with cutting-edge molecular biology and clinical expertise, underscores the university's commitment to transforming cancer care.

About Oncodia AB

Oncodia is an innovative Medical Technology company based in Uppsala, Sweden. Oncodia is committed to providing in vitro diagnostic products that consistently meet customer needs, enhance patient treatment outcomes and adhere to regulatory and statutory requirements. Oncodia provides CE/IVD software for precision cancer medicine as well as CE/IVD products for DNA/RNA isolation from diagnostic tissue specimens. Their focus is to supply clinical pathology and oncology with the right solutions for optimal molecular diagnostics of solid tumors.

Forward-Looking Statements

Statements in this press release that are not strictly historical in nature are forward-looking statements. These statements are only predictions based on current information and expectations and involve a number of risks and uncertainties, including but not limited to the success or efficacy of our pipeline, platform and fundraising. All statements other than historical facts are forward-looking statements, which can be identified by the use of forward-looking terminology such as “believes,” “plans,” “expects,” “aims,” “intends,” “potential,” or similar expressions. Actual events or results may differ materially from those projected in any of such statements due to various uncertainties, including as set forth in Renovaro’s most recent Annual Report on Form 10-K filed with the SEC. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof. All forward-looking statements are qualified in their entirety by this cautionary statement, and Renovaro Inc. undertakes no obligation to revise or update this press release to reflect events or circumstances after the date hereof.

Investor Relations

Chris Tyson
Executive Vice President
MZ Group - MZ North America
949-491-8235
[e-mail]
www.mzgroup.us

For media inquiries, please contact:

[e-mail] and [e-mail]

https://www.globenewswire.com/newsroom/ti?nf=OTMyMzM0MCM2NjY5MjkwIzIxMjA2Nzk=
https://ml.globenewswire.com/media/ZmQxZTY1ZDUtNWEyNS00MWFlLTg0NGMtYTllYWI2ZDU0MWZlLTExMzIyNTA=/tiny/Renovaro-Inc.png

Source: Renovaro Inc

[ProfitScout]

$CHSN Feature: First Half of 2024 Total Revenue of $7.5 Million and Operating at a Profit.
Benzinga Article:
https://www.benzinga.com/partner/movers-shakers/24/12/42292112/chanson-international-closing-the-year-in-expansion-mode

[Golden Cross]

$ILLR Bare Knuckle Fighting Championship, the first sanctioned bare-knuckle fighting company in history, is quickly becoming the #1 combat sport in the world.
https://trillercorp.com/bare-knuckle-fighting-championship/

[ProfitScout]

$ACGX: Alliance Creative Group (ACGX) Releases Q3 2024 Financial and Disclosure Report with an increase of over 100% in Net Income for 1st 9 months of 2024 vs 2023

No New Free Trading Shares have been issued for over 8 months

CHICAGO, Nov. 14, 2024 /PRNewswire/ -- Alliance Creative Group, Inc., (http://www.ACGX.us) (Stock Symbol OTC: ACGX) is pleased to announce the results of Operations for the Quarter Ending September 30, 2024.

Revenues for the Quarter ending September 30, 2024 ("Q3 2024") were $102,990 Gross Profits for the Quarter ending September 30, 2024 ("Q3 2024") were $102,990 Net Income for the Quarter ending September 30, 2024 ("Q3 2024") were ($44,912)

The total assets on the Balance Sheet for the Alliance Creative Group as of 9/30/24 were $4,543,643

The total outstanding common shares as of September 30, 2024 were 4,454,211 with 2,799,023 of those shares in the float - Same as the end of the last quarter, and since March.

The Company ended the quarter with $88,220 Cash on hand.

The property located at 1324 W. Devon Ave, Chicago, IL. 60660 has lowered its asking pricing and hopes to sell before the end of the year.

The full financial statement, balance sheet, statement of operations, cash flow statement, and disclosure statements are posted on the OTC Market Company website at http://www.OTCmarkets.com under the stock symbol ACGX in the section for filings and disclosure and on http://www.ACGX,us in the investor relations section.

Paul Sorkin, CEO of the Alliance Creative Group, Inc. said, "We continue to look for future opportunities, however, nothing has been a good fit yet. Our goal is to reduce the price significantly with the 1324 W. Devon Ave property so we can sell it before the end of the year and increase our search for the next opportunity. Our shares of www.PeopleVine.com continue to be by far our strongest investment and the conversations with the growth capital investment groups have been avery positive experience with lots of interest. Our goal is to convert between 20% and 30% of the PeopleVine investment into cash in 2025 so we can use a lot of it to invest in future projects while we let the majority of the shares hopefully continue to increase in value.

We haven't issued any new free trading shares in over 8 months now and we are still in search of other strategic investments, acquisitions, or partnerships in Real Estate or in a small business with good potential to grow. We will continue to update the public as things progress and will share more details as they become available."

About Alliance Creative Group, Inc.

Alliance Creative Group, Inc. (Stock Symbol: ACGX) is a Parent Holding Company on the OTC market. The strategy ACG intends to deploy is a shared resource model where internal divisions, portfolio companies, Real Estate projects, and strategic investments are vertically integrated, optimizing efficiencies and cost savings. Resources may be applied to a mix of early-stage equity investments in companies that synergize with the company's shared resource model and secured investment opportunities. ACG's strategic mission is to utilize a unique blend of capital, relationships, experience, and secured investment structures to increase value for its clients, partners, investors, and shareholders while reducing the overall risk. The company's big picture long term plan is to create an ecosystem of shared resources that can provide quality resources with reduced expenses while acting as a partner for internal projects. The intent is to have multiple businesses and investment projects or divisions to help diversify the risk and generate potential revenue in multiple ways while leveraging both the private and public markets. For more information, visit http://www.AllianceCreativeGroup.com or http://www.ACGX.us.

About PeopleVine

PeopleVine is a Software as a Service (SAAS) company that specializes in serving the Lifestyle Hospitality industry. The Member Experience & CRM Software allows luxury hotels, resorts, and private member clubs to elevate a more personalized online membership experience. PeopleVine helps their clients build member communities, drive engagement, and connect the dots that elevate experiences and revenues. The software empowers its clients teams to deliver efficiently managed operations through an integrated platform. PeopleVine is committed to being the most essential and adaptive SaaS engagement platform for companies that take a customer centric approach to business.

For more information http://www.PeopleVine.com

This news release contains forward-looking statements as defined by the bespeaks-caution doctrine. Forward-looking statements include statements concerning plans, objectives, goals, strategies, future events or performance, and underlying assumptions and other statements that are other than statements of historical facts. These statements are subject to uncertainties and risks including, but not limited to, product and service demand and acceptance, changes in technology, economic conditions, the impact of competition and pricing, government regulation, and other risks described in statements filed from time to time with the Securities and Exchange Commission. All such forward-looking statements, whether written or oral, and whether made by or on behalf of the Company, are expressly qualified by the cautionary statements that may accompany the forward-looking statements. In addition, the Company disclaims any obligation to update any forward-looking statements to reflect events or circumstances after the date hereof.

Investor Relations and Media Contact

1-312-498-9769, [e-mail]

Cision View original content:https://www.prnewswire.com/news-releases/alliance-creative-group-acgx-releases-q3-2024-financial-and-disclosure-report-with-an-increase-of-over-100-in-net-income-for-1st-9-months-of-2024-vs-2023-302304712.html

SOURCE Alliance Creative Group, Inc.

[ProfitScout]

$CHSN News: Chanson International Holding Announces a Collaboration under Coffee Brand Soul * Song in Xinjiang, China

URUMQI, China, Nov. 25, 2024 (GLOBE NEWSWIRE) -- Chanson International Holding (Nasdaq: CHSN) (the “Company” or “Chanson”), a provider of bakery, seasonal, and beverage products through its chain stores in China and the United States, today announces a collaboration with a leading hotel and restaurant management enterprise in Yili, Xinjiang, China, Xinjiang Hengtai Investment Co., Ltd. (“Xinjiang Hengtai”) to expand its coffee brand, Soul * Song, through a franchise operation model in Yili. This milestone marks significant progress in the development of Chanson’s Soul * Song brand, further deepening its market presence and extending its brand influence in the Xinjiang region.

In July 2024, the Company celebrated the grand opening of a Soul * Song café in partnership with Xinjiang Hengtai at the scenic Nalati National Tourist Resort in Yili, Xinjiang, China. Soul ? Song’s innovative "blend bean concept" highlights the art of blending, offering diverse flavors to suit every customer's unique taste. The café quickly became a must-visit destination within the resort, breaking the Company's single-day coffee-related sales record by achieving daily sales of RMB 30,000 on both August 8 and August 15, 2024. This marks Chanson's first attempt in adopting a franchise model, partnering with a distinguished local enterprise for mutual growth and success. Building on its growing influence in the Yili region, the Company plans to open five additional Soul ? Song cafés under the franchise model by 2025.

Mr. Gang Li, Chairman of the Board of Directors and Chief Executive Officer of Chanson, commented, “The introduction of the franchise model is a key milestone in the growth of our Soul * Song brand, and underscoring a commitment to enhancing our marketing strategy and brand visibility. After thorough investigation and analysis, we selected the picturesque and culturally rich 5A-level tourist resort in Nalati as the ideal location to showcase our brand’s uniqueness and positioning within a high-quality consumption environment. 5A-level tourist resort is the highest rating by government, awarded to China’s most important and well-maintained tourist attractions. Our goal is to provide consumers with an unprecedented experience that combines food and cultural elements. We believe that this franchise model will foster sustainable growth for Chanson while contributing to the vitality of Xinjiang’s local tourism economy.”

About Chanson International Holding
Founded in 2009, Chanson International Holding is a provider of bakery, seasonal, and beverage products through its chain stores in China and the United States. Headquartered in Urumqi, China, Chanson directly operates stores in Xinjiang, China and New York, United States. Chanson currently manages stores in China and in New York City while selling on digital platforms and third-party online food ordering platforms. Chanson offers not only packaged bakery products but also made-in-store pastries and eat-in services, serving freshly prepared bakery products and extensive beverage products. Chanson aims to make healthy, nutritious, and ready-to-eat food through advanced facilities based on in-depth industry research, while creating a comfortable and distinguishable store environment for customers. Chanson's dedicated and highly-experienced product development teams constantly create new products that reflect market trends to meet customer demand. For more information, please visit the Company's website: http://ir.chanson-international.net/.

Forward-Looking Statements

Certain statements in this announcement are forward-looking statements. These forward-looking statements involve known and unknown risks and uncertainties and are based on the Company's current expectations and projections about future events that the Company believes may affect its financial condition, results of operations, business strategy and financial needs. Investors can identify these forward-looking statements by words or phrases such as "approximates," "believes," "hopes," "expects," "anticipates," "estimates," "projects," "intends," "plans," "will," "would," "should," "could," "may" or other similar expressions. The Company undertakes no obligation to update or revise publicly any forward-looking statements to reflect subsequent occurring events or circumstances, or changes in its expectations, except as may be required by law. Although the Company believes that the expectations expressed in these forward-looking statements are reasonable, it cannot assure you that such expectations will turn out to be correct, and the Company cautions investors that actual results may differ materially from the anticipated results and encourages investors to review other factors that may affect its future results in the Company's registration statement and other filings with the U.S. Securities and Exchange Commission.

For investor and media inquiries, please contact:

Chanson International Holding
Investor Relations Department
Email: [e-mail]

Ascent Investor Relations LLC
Tina Xiao
Phone: [phone]
Email: [e-mail]

[Golden Cross]

$ILLR The Triller Universe is an #AI Powered Social Media Powerhouse.
https://youtube.com/watch?v=zVkE9IApYW0

[ProfitScout]

$BLIS has issued 4 extremely positive announcements in just the last couple of weeks. These include a signed LOI on a $370 Million defense contract in the Middle East (See Oct. 22nd news below).

Oct. 29, 2024: NAPC Defense and Lamperd Less Lethal form Partnership for Security Products Marketing in The USA and Worldwide
https://www.morningstar.com/news/globe-newswire/9263212/napc-defense-and-lamperd-less-lethal-form-partnership-for-security-products-marketing-in-the-usa-and-worldwide

Oct. 25, 2024: NAPC Defense (OTCPK: BLIS) to Demonstrate Corner Shot and Attend SWAT Round-Up 2024 as a Convention Exhibitor

The Company Plans to Meet with leading SWAT Team Members, Law Enforcement Officers, Military Personnel, and other Industry Experts
https://www.globenewswire.com/en/news-release/2024/10/25/2969429/0/en/NAPC-Defense-OTCPK-BLIS-to-Demonstrate-Corner-Shot-and-Attend-SWAT-Round-Up-2024-as-a-Convention-Exhibitor.html

Oct. 24, 2024: NAPC Defense (OTCPK: BLIS) Awarded in Excess of $1 Million in Clean-up Contracts following Hurricanes Helene and Milton

The Company is Working on Additional Potential Restoration and Clean-up Contracts
https://finance.yahoo.com/news/napc-defense-otcpk-blis-awarded-120500313.html?soc_src=social-sh&soc_trk=tw&tsrc=twtr

Oct. 22, 2024: NAPC Defense, Inc. (OTCPK: BLIS) issues Progress Report regarding Large Contract with Saudi Arabia
https://www.globenewswire.com/news-release/2024/10/22/2966948/0/en/NAPC-Defense-Inc-OTCPK-BLIS-issues-Progress-Report-regarding-Large-Contract-with-Saudi-Arabia.html

[ProfitScout]

$NRXP News: NRx Pharmaceuticals, Inc. (Nasdaq:NRXP) Featured on Psychiatrist.com

"How NRx Could Upend the Fight Against Depression and Suicide"

RADNOR, Pa., Sept. 11, 2024 /PRNewswire/ -- NRx Pharmaceuticals, Inc. (Nasdaq: NRXP), a clinical-stage biopharmaceutical company, ("NRx," the "Company"), today highlighted that the Company's pipeline products NRX-100 and NRX-101 were featured in an article published on Psychiatrist.com. This prominent outlet is the home of the Journal of Clinical Psychiatry, the official journal of the American Society of Clinical Psychopharmacology.

The article, entitled "How NRx Could Upend the Fight Against Depression and Suicide," can be found here. The author notes:

"Clinical relevance: NRX Pharmaceuticals is developing a pair of promising new treatments for bipolar depression and suicidal ideation."
"NRX-101 is a twice-daily fixed-dose oral combination of D-cycloserine and lurasidone the company developed to treat suicidal treatment-resistant bipolar depression. Researchers found this combination showed a higher efficacy than lurasidone alone for reducing akathisia and suicidality."
"NRX-100 is a proprietary preservative-free formulation of IV ketamine. Researchers have studied it as a treatment for acute suicidal crises in depression."
For more information, please visit http://www.nrxpharma.com.

About NRx Pharmaceuticals, Inc.
NRx Pharmaceuticals is a clinical-stage biopharmaceutical company developing therapeutics based on its NMDA platform for the treatment of central nervous system disorders, specifically suicidal bipolar depression, chronic pain, and PTSD. The Company is developing NRX-101, an FDA-designated investigational Breakthrough Therapy for suicidal treatment-resistant bipolar depression and chronic pain. NRx plans to file an NDA for Accelerated Approval for NRX-101 in patients with bipolar depression and suicidality or akathisia. NRX-101 additionally has potential to act as a non-opioid treatment for chronic pain, as well as a treatment for complicated UTI.

NRx has recently announced plans to submit a New Drug Application for NRX-100 (IV ketamine) for the treatment of suicidal depression, based on results of well-controlled clinical trials conducted under the auspices of the US National Institutes of Health and newly obtained data from French health authorities, licensed under a data sharing agreement. NRx was awarded Fast Track Designation for development of ketamine (NRX-100) by the US FDA as part of a protocol to treat patients with acute suicidality.

Notice Regarding Forward-Looking Statements

The information contained herein includes forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, and Section 27A of the Securities Act of 1933, as amended. These statements include, among others, statements regarding the proposed public offering and the timing and the use of the proceeds from the offering. Forward-looking statements generally include statements that are predictive in nature and depend upon or refer to future events or conditions, and include words such as "may," "will," "should," "would," "expect," "plan," "believe," "intend," "look forward," and other similar expressions among others. These statements relate to future events or to the Company's future financial performance, and involve known and unknown risks, uncertainties and other factors that may cause the Company's actual results to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. You should not place undue reliance on forward-looking statements since they involve known and unknown risks, uncertain